This trial is evaluating whether The Endogenex Device will improve 1 primary outcome, 9 secondary outcomes, and 2 other outcomes in patients with Endocrine System Diseases. Measurement will happen over the course of 12 weeks post-procedure.
This trial requires 20 total participants across 1 different treatment group
This trial involves a single treatment. The Endogenex Device is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
"Symptoms that may indicate diabetes type 2 include numbness and tingling in the feet which are unrelated to peripheral neuropathy, and it is important to remember that even in the absence of these symptoms, the diagnosis of diabetic neuropathy is justified." - Anonymous Online Contributor
"Diabetes type 2 is a genetically determined disorder affecting about 5% of the population and increasing with frequency. It is a serious condition that impairs daily life and can be avoided. People with diabetes should take an active role in controlling their condition." - Anonymous Online Contributor
"Patients with diabetes type 2 who continue their dietary regimen that keeps A1C > 7.0 % will see a significant decrease in beta-cell production. Over time, beta cells will become more productive. Those who do not respond to high-dose treatment will not improve at this rate." - Anonymous Online Contributor
"Some of the treatments for [type 2 diabetes](https://www.withpower.com/clinical-trials/type-2-diabetes), such as weight loss therapy or hypoglycemic medicines, are commonly used by patients with type 2 diabetes, but not by those with type 1 diabetes. The other treatments, such as insulin pump therapy, were commonly used by both type 1 and type 2 patients with diabetes.\n" - Anonymous Online Contributor
"The first clinical manifestation of [diabetes type 2](https://www.withpower.com/clinical-trials/diabetes-type-2) is impaired fasting glucose (IFG). Later abnormalities are manifest in diabetes as impaired glucose tolerance (IGT) or type 2 diabetes (T2DM)." - Anonymous Online Contributor
"Diabetes type 2 is highly prevalent and will become more so. The incidence of [diabetes type 2](https://www.withpower.com/clinical-trials/diabetes-type-2) will be even higher if treatment rates remain low. Diabetes mellitus had been considered as a high-risk disease in previous reports, however, recent studies have suggested that it should be considered to be a low-risk disease too." - Anonymous Online Contributor
"The endogenex device is well tolerated and effective in controlling blood glucose levels in patients with both T2DM and IGT/impaired glucose tolerance. The side effects reported include nausea, abdominal discomfort, sore mouth and throat, fatigue, and upper gastrointestinal distress. In conclusion, the endogenex device is a safe, reliable treatment modality for patients with T2DM and IGT/impaired glucose tolerance." - Anonymous Online Contributor
"Results from a recent clinical trial does not support the claim that the EMD-100 has an effect on insulin response to the OGTT. It may be possible to better define the endogenex device's place in the treatment of individuals with type 2 diabetes." - Anonymous Online Contributor
"Results from a recent paper highlight the role of genetic susceptibility, which is clearly present in the first 20 years of life, as the most significant risk factor for diabetes type 2. Results from a recent paper also emphasize the importance of implementing genetic screening programmes for children at the family level." - Anonymous Online Contributor
"It is hard to convince the patients that they benefit from being included in an RCT, and the investigators’ perceptions that type 2 diabetes patients do not respond well to randomised clinical trials is not supported by the findings of studies which have been conducted thus far in type 2 diabetes. Patients must also be informed of the possibility of severe adverse events that are associated with an RCT." - Anonymous Online Contributor
"EndocrineEX device could be a useful tool to improve QOL in people with type 2 diabetes because of its positive effects on treatment adherence, weight loss, and self-care." - Anonymous Online Contributor
"There are a handful of other devices with claims to be able to reverse type 2 diabetes. However, none have been subjected to clinical trials to document their safety and efficacy, and none employ the clinical research-grade technology of endogenex. Endogenex is a well-established device used by a single company in a variety of clinical trials that are completed only in the United States under an FDA review process. These trials are carefully monitored and monitored, with the manufacturer providing documentation that any data collected are used only from human subjects in the research without compensation or product sales and that the device has been validated." - Anonymous Online Contributor